Ciprofloxacin (Ciprodex Iv ) is a fluoroquinolone antibiotic, prescribed for certain types of bacterial infections such as pneumonia, urinary tract, skin, bones and joint infections. It is also used ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

Dr. Reddy’s is releasing the first generic of Bayer's Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%) otic suspension. The drug is indicated to treat acute otitis media in pediatric patients with ...

MAPLE GROVE, Minn., April 6, 2026 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX) today announced the recent ...

Ciprofloxacin and dexamethasone otic suspension is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in Acute Otitis Externa. Amneal has ...

USA: Dr. Reddy’s Laboratories Ltd today announced the launch of Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP, a therapeutic equivalent generic version of Ciprodex® (ciprofloxacin 0.3 ...

Pharma major Dr. Reddy’s Laboratories on Tuesday said it has launcheda generic version of Ciprodex (Ciprofloxacin 0.3% and Dexamethasone 0.1%) Otic Suspension, USP, in the U.S. market. A therapeutic ...

Hyderabad-based pharma major Dr Reddy’s Laboratories on Tuesday said it has launched Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP, in the US market following approval by the US Food ...

Hyderabad, Aug 11 () Dr Reddys Laboratories Ltd on Tuesday announced the launch of a generic version of Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension in the American market, ...

Dr Reddy’s Laboratories Ltd has launched Ciprofloxacin and Dexamethasone Otic Suspension in the US market. The products are a therapeutic equivalent generic version of Ciprodex (ciprofloxacin 0.3 per ...